Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01014819 · ClinicalTrials.gov registry record
A Clinical Trial of Dermacorder for Detecting Malignant Skin Lesions
A clinical trial, sponsored by UCSF Benioff Children's Hospital Oakland.
- Completed
- Registry status
- 30
- Enrollment target
NCT01014819: Completed study, sponsored by UCSF Benioff Children's Hospital Oakland.
NCT01014819 is a clinical trial that has completed, run by UCSF Benioff Children's Hospital Oakland. The registered enrollment target is 30 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01014819 has completed, sponsored by UCSF Benioff Children's Hospital Oakland.
- COMPLETED
- Registry status
- 30 participants
- Enrollment target
Study Summary
The Dermacorder measures the electric field in the skin. Malignant skin lesions disrupt the skin's normal electric field and this abnormal electric field can be detected by the Dermacorder. Therefore the investigators are testing the hypothesis that the Dermacorder can provide useful data to guide in the diagnosis of skin disease.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2009-10 |
| Est. Completion | 2011-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01014819
The ClinicalTrials.gov registry entry for NCT01014819 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is UCSF Benioff Children's Hospital Oakland, which has 52 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01014819 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01014819 about?
NCT01014819 is a clinical study titled "A Clinical Trial of Dermacorder for Detecting Malignant Skin Lesions". The Dermacorder measures the electric field in the skin. Malignant skin lesions disrupt the skin's normal electric field and this abnormal electric field can be detected by the Dermacorder. Therefore the investigators are testing the hypothesis that the Dermacorder can provide useful data to guide i...
What is the current status of trial NCT01014819?
This trial is currently completed. The enrollment target is 30 participants. The study started on 2009-10. Estimated completion is 2011-07.
Who is sponsoring clinical trial NCT01014819?
This trial is sponsored by UCSF Benioff Children's Hospital Oakland, which has 52 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.